Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC
Clinical trial NCT02504489 · COMPLETED
Trial details
- NCT number
- NCT02504489
- Sponsor
- BeyondSpring Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2021-07-21
- Enrollment
- 559
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.